Depressions following reserpine: a reevaluation.
D000284:Administration, Oral; D003863:Depression / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy / Q000628:therapy; D004325:Dreams / Q000187:drug effects; D004359:Drug Therapy, Combination; D004565:Electroconvulsive Therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007099:Imipramine / Q000031:analogs & derivatives / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D018377:Neurotransmitter Agents / Q000378:metabolism; D012110:Reserpine / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D012306:Risk; D012890:Sleep / Q000187:drug effects; D013997:Time Factors
D008996:Monoamine Oxidase Inhibitors; D018377:Neurotransmitter Agents; D012110:Reserpine; D007099:Imipramine